Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Genomics Market to be Worth $70.52 Billion by 2031--Exclusive Report by…
Genomics is the study of genes and their function, including genome organization, structure, function, and evolution. It involves analyzing the DNA sequence and studying the interactions between genes, environmental factors, and individual characteristics to gain a comprehensive understanding of the biological systems and processes that regulate life. Genomics plays an essential role in personalized medicine, genetic counseling, biotechnology, and drug development. Genomics is the study of...
PR Newswire
08/05/2024
Veterinary Rapid Test Market to reach USD 2870 Million by 2034 | Future Market…
The growing prevalence of zoonotic diseases in developed and developing regions is projected to surge demand for rapid disease diagnostics and veterinary rapid test kits. Increasing demand for animal products in developing economies is a key factor projected to propel the veterinary rapid test market. The growing prevalence of zoonotic diseases in developed and developing regions is projected to surge demand for rapid disease diagnostics and veterinary rapid test kits. Increasing demand for...
PR Newswire
08/05/2024
Company Hiring Nicotine Pouch Tester with a Monthly Salary of 2800 Euros
The company Premium Pouch UK Ltd is advertising for a product tester for nicotine pouches. This is a remote position with a monthly salary of 2800 euros. The company Premium Pouch UK Ltd is advertising for a product tester for nicotine pouches. This is a remote position with a monthly salary of2800 euros. The main responsibilities include testing new and existing company products and providing feedback on their quality, flavor, composition, and usability, as outlined in the advertisement...
PR Newswire
08/05/2024
Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts…
Live cases performed during EPLive 2024 featured commercially approved pulsed field ablation (PFA) systems—the biggest advancement in the electrophysiology (EP) field in decades. The first commercially approved PFA case in the U.S. was performed earlier this year by physicians at TCAI. PFA produces high-frequency electrical pulses to destroy muscle cells that cause irregular heart rhythms without using excess heat or cold. The non-thermal approach does not damage surrounding tissue and…
PR Newswire
08/05/2024
Skincare Supplement Market to Reach US$ 4,500 Million by 2034 Amid Rising Shift…
Functionalities such as skin de-aging, wounds & marks healing, skin brightening, skin hydrating, and acne reduction have captured the demand for effective skincare products and are driving growth. The shift of consumers toward natural and organic alternatives of harmful skincare creams and gels, as well as rising awareness among consumers regarding preventive healthcare, are principal factors for a strong growth rate. Functionalities such as skin de-aging, wounds & marks healing, skin...
PR Newswire
08/05/2024
Sexual Wellness Market to Reach $32.5 billion, Globally, by 2033 at 4.7% CAGR…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A06393 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A06393 Prime determinants of growth Health and wellness trends play a pivotal role in driving the growth of the sexual wellness market by fostering a culture of self-care and holistic well-being. As individuals increasingly prioritize their physical, mental, and emotional health, they...
PR Newswire
08/05/2024
Trading by management and close relations of management
Please read the full announcement in PDFAttachment 2024_16_Trading_By_Management
Nasdaq GlobeNewswire
08/05/2024
Implantica presents the first quarter 2024 on May 15 at 15:00 CEST
If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 (0)79 335 09 49nicole...
PR Newswire
08/05/2024
SURVEY: Consumers Want More Live Interactive Shopping Events
Live shopping is anticipated to grow into a mainstream online retail avenue, significantly transforming the consumer shopping experience. As retailers and marketplaces strategically position themselves to harness this burgeoning trend, they are shifting focus to curating immersive, unforgettable experiences that transcend the digital realm and provide a competitive edge in the evolving marketplace. Live shopping is anticipated to grow into a mainstream online retail avenue, significantly...
PR Newswire
08/05/2024
Maybelline New York embarks on long-term global partnership with the WHO…
As part of the Brave Together program, Maybelline New York has a goal of helping 10 million people access 1:1 mental health support and donating $20 million to this cause by 2030. As part of the Brave Together program, Maybelline New York has a goal of helping 10 million people access 1:1 mental health support and donating$20 millionto this cause by 2030. "Maybelline New York's mission is to give everyone the self-confidence they need to express their beauty. We know that makeup has a...
PR Newswire
08/05/2024
Signant Health extends eCOA leadership position through operational innovations…
According to the company, customers can now benefit from this highly customizable eCOA solution along with Signant's leading levels of science, scale, and service – delivered under much faster timelines. According to the company, customers can now benefit from this highly customizable eCOA solution along with Signant's leading levels of science, scale, and service – delivered under much faster timelines. "We are excited to offer customers the best of both worlds," saidSanjiv…
PR Newswire
08/05/2024
OKYO Pharma Announces Participation in May 2024 Investor Conferences
LONDON and NEW YORK, May08, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, today announced upcoming presentations at two investor conferences in May 2024...
Nasdaq GlobeNewswire
08/05/2024
Compass Pathways Announces First Quarter 2024 Financial Results and Business…
COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, COMP006 trial top-line data expected mid-2025Compass announces positive phase 2 COMP360 data in post-traumatic stress disorder (PTSD)Michael Gold to join Compass as Head of R&DCompass enters into additional commercial collaborations, including with Reliant Medical Group, part of Optum Care Cash position of $262.9 million at March 31,...
Nasdaq GlobeNewswire
08/05/2024
Compass Pathways announces durable improvement in symptoms through 12 weeks in…
Study met primary safety endpoint; administration was well tolerated, with no serious adverse events observed Early and clinically meaningful improvement from baseline in mean CAPS-5 total score (29.5 point reduction at week 12), with change from baseline in mean SDS total score (14.4 point reduction at week 12)81.8% response (reduction of ≥ 15 points in CAPS-5 score), 63.6% remission (total CAPS-5 ≤ 20) rates at week 4 with 77.3% response and 54.5% remission at week 12 Measures...
Nasdaq GlobeNewswire
08/05/2024
Metalworking Fluids Market worth $14.7 billion by 2029 - Exclusive Report by…
Browse in-depth TOC on "Metalworking Fluids Market". Browse in-depth TOC on "Metalworking Fluids Market". 310 – Tables 59 – Figures 266 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116835111 Soluble oils are projected to register the highest CAGR, in terms of value, of the global metalworking fluids market during the forecast period. The metalworking fluids market is set to grow significantly during the forecast period...
PR Newswire
08/05/2024
Sobi has completed SEK 3 billion senior bond issue
The bond issue generated strong investor interest and was oversubscribed. The bond issue generated strong investor interest and was oversubscribed. The bonds will be listed on Nasdaq Stockholm. Nordea and SEB acted as lead managers on the transaction. Mannheimer Swartling Advokatbyrå acted as legal adviser to Sobi. Sobi Sobi ®is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to...
PR Newswire
08/05/2024
Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult…
"Today's approval underscores the robust clinical data supporting Aspaveli's efficacy and safety profile, offering healthcare professionals and patients an expanded toolkit for effectively managing PNH," said Lydia Abad-Franch MD, Head of R&D and Medical Affairs, and Chief Medical Officer at Sobi. "European patients will now be able to initiate treatment with Aspaveli at diagnosis or switch from their current C5 inhibitor treatment if they present indicators of haemolytic…
PR Newswire
08/05/2024
Chamlion Unveils Advanced Dental 3D Printing Solutions at IDEX 2024 Exhibition
Chamlion experts will be available at the booth to provide demonstrations of the complete workflow, and discuss how their solutions can transform dental lab operations. Attendees are invited to visit the Chamlion booth #4-A21 at IDEX 2024 to experience these innovations firsthand. Chamlion experts will be available at the booth to provide demonstrations of the complete workflow, and discuss how their solutions can transform dental lab operations. Attendees are invited to visit the Chamlion...
PR Newswire
08/05/2024
Tableware Market to Reach $109.9 Billion Globally by 2032 at 9.3% CAGR: Allied…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A62339 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A62339 Prime Determinants of Growth The increase in popularity of biodegradable tableware and the growing emphasis on dining experiences & home aesthetics are the factors expected to drive the growth of the global tableware market in the forecast period from 2023 to 2032. However,...
PR Newswire
08/05/2024
Orexo Q1 2024 Interim Report
Q1 2024 highlights Q1 2024 highlights Important events after the end of the period CEO Comments in brief: Creating a stable financial platform I am pleased to report a significant improvement in our financial results with an EBITDA increasingSEK 57 millionand amounted toSEK 16 million(-41). In addition to less non-repeating activities, it is driven by efficiency improvements and cost control. Improving our financial results was a cornerstone of successfully...
PR Newswire
08/05/2024
Finnish Hospital Orders Nexstim NBS System 5
Press release, Helsinki, 8 May 2024 at 9 AM (EEST)Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a hospital in Finland. This is a new customer to Nexstim.The Nexstim Navigated Brain Stimulation (NBS) System 5 is indicated for non-invasive mapping of the primary motor cortex of the brain to its cortical gyrus. The system provides information that may be used in the assessment of…
Nasdaq GlobeNewswire
08/05/2024
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme…
COPENHAGEN, Denmark, May 8, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a new share buy-back program, under which the Company intends to buy back up to 162,288 of its own shares. The purpose of the share buy-back program is to meet the Company's obligations arising from the share-based incentive programs for the Board of Directors and Executive Management, in accordance with the Company's remuneration policy.The share buy-back program is initiated pursuant to...
Nasdaq GlobeNewswire
08/05/2024
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
COPENHAGEN,Denmark, May 8, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2024. Revenue for the first three months was DKK 831 million, and the operating profit (EBITDA) was DKK 22 million.Revenue from travel health increased by 20% to DKK 447 million and revenue from public preparedness was DKK 344 million, 59% down from first quarter 2023, which is fully in line with expectations after a...
Nasdaq GlobeNewswire
08/05/2024
Pharming Group reports first quarter 2024 financial results and provides…
First quarter 2024 revenues increased by 31% to US$55.6 million, compared to the first quarter 2023, driven by the U.S. commercial launch of Joenja® and revenue growth of RUCONEST®RUCONEST® revenues increased by 8% to US$46.0 million, compared to the first quarter 2023Joenja® (leniolisib) revenue of US$9.6 million, a 21% increase compared to the fourth quarter of 2023On track for 2024 total revenue guidance of US$280 million - US$295 million (14 - 20% growth)Overall cash and...
Nasdaq GlobeNewswire
08/05/2024
Altri Comunicati
